Literature DB >> 3337211

Proliferative and secretory activity in human breast during natural and artificial menstrual cycles.

J J Going1, T J Anderson, S Battersby, C C MacIntyre.   

Abstract

Events of cell proliferation have been assessed by thymidine labeling index (TLI) in morphologically normal breast lobules from women of reproductive age. TLI is higher during the second half of the menstrual cycle both in women with natural menstrual cycles and in those with artificial cycles due to oral contraceptive (OC) use. TLI varies between 0.04% and 5.7% and declines with increasing age. There is no difference in mean TLI between OC users and nonusers if correction is made for the difference in age distribution between these two groups. Immunohistochemical detection of immunoglobulin A (IgA), secretory component (SC), and alpha-lactalbumin shows more frequent positive staining during artificial than natural menstrual cycles, and positive staining tends to be associated with higher TLI values. No significant variation in staining with cycle phase is detected in natural or artificial cycles. These results show that breast tissue does not resemble endometrium in the relationships that exist between proliferation, secretion, and menstrual cycle phase.

Entities:  

Keywords:  Biology; Contraception; Contraceptive Methods--pharmacodynamics; Endometrium; Family Planning; Genitalia; Genitalia, Female; Hematological Effects; Hemic System; Immunoglobulin Alterations; Mammary Gland Effects; Menstrual Cycle; Menstruation; Oral Contraceptives--pharmacodynamics; Physiology; Proteins; Reproduction; Urogenital System; Uterus

Mesh:

Substances:

Year:  1988        PMID: 3337211      PMCID: PMC1880536     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  27 in total

1.  EVALUATION OF A SIMPLE METHOD OF SAMPLING THE LUNG FOR QUANTITATIVE HISTOLOGICAL ANALYSIS.

Authors:  M S DUNNILL
Journal:  Thorax       Date:  1964-09       Impact factor: 9.139

2.  Radioimmunoassay of human epidermal growth factor (urogastrone).

Authors:  R H Starkey; D N Orth
Journal:  J Clin Endocrinol Metab       Date:  1977-12       Impact factor: 5.958

Review 3.  Mode of action of contraceptive drugs.

Authors:  E Diczfalusy
Journal:  Am J Obstet Gynecol       Date:  1968-01-01       Impact factor: 8.661

4.  Direct evidence for an integrated function of J chain and secretory component in epithelial transport of immunoglobulins.

Authors:  P Brandtzaeg; H Prydz
Journal:  Nature       Date:  1984 Sep 6-11       Impact factor: 49.962

5.  Homologous radioimmunoassay for human epidermal growth factor (urogastrone).

Authors:  G E Dailey; J W Kraus; D N Orth
Journal:  J Clin Endocrinol Metab       Date:  1978-06       Impact factor: 5.958

6.  The correlation of histologic changes in the human breast with the menstrual cycle.

Authors:  P M Vogel; N G Georgiade; B F Fetter; F S Vogel; K S McCarty
Journal:  Am J Pathol       Date:  1981-07       Impact factor: 4.307

7.  Estradiol regulation of secretory component in the uterus of the rat: evidence for involvement of RNA synthesis.

Authors:  C R Wira; J E Stern; E Colby
Journal:  J Immunol       Date:  1984-11       Impact factor: 5.422

8.  Cell proliferation in normal human breast ducts, fibroadenomas, and other ductal hyperplasias measured by nuclear labeling with tritiated thymidine. Effects of menstrual phase, age, and oral contraceptive hormones.

Authors:  J S Meyer
Journal:  Hum Pathol       Date:  1977-01       Impact factor: 3.466

9.  The effect of estrogen, progesterone, thyroxine, and human placental lactogen on DNA synthesis of human breast ductal epithelium maintained in athymic nude mice.

Authors:  M J McManus; C W Welsch
Journal:  Cancer       Date:  1984-11-01       Impact factor: 6.860

10.  Morphological evaluation of cell turnover in relation to the menstrual cycle in the "resting" human breast.

Authors:  D J Ferguson; T J Anderson
Journal:  Br J Cancer       Date:  1981-08       Impact factor: 7.640

View more
  46 in total

Review 1.  Estrogen responsiveness and control of normal human breast proliferation.

Authors:  E Anderson; R B Clarke; A Howell
Journal:  J Mammary Gland Biol Neoplasia       Date:  1998-01       Impact factor: 2.673

Review 2.  Apoptosis in the estrous and menstrual cycles.

Authors:  A C Andres; R Strange
Journal:  J Mammary Gland Biol Neoplasia       Date:  1999-04       Impact factor: 2.673

Review 3.  Progesterone signaling and mammary gland morphogenesis.

Authors:  G Shyamala
Journal:  J Mammary Gland Biol Neoplasia       Date:  1999-01       Impact factor: 2.673

Review 4.  [Anatomy of the breast].

Authors:  W Böcker; D Hungermann; T Decker
Journal:  Pathologe       Date:  2009-02       Impact factor: 1.011

Review 5.  A perspective of comparative salivary and breast pathology. Part I: microstructural aspects, adaptations and cellular events.

Authors:  Asterios Triantafyllou; Jennifer L Hunt; Kenneth O Devaney; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-05-07       Impact factor: 2.503

6.  The endogenous progesterone metabolite, 5a-pregnane-3,20-dione, decreases cell-substrate attachment, adhesion plaques, vinculin expression, and polymerized F-actin in MCF-7 breast cancer cells.

Authors:  J P Wiebe; D Muzia
Journal:  Endocrine       Date:  2001-10       Impact factor: 3.633

Review 7.  The contraceptive pill and breast cancer in young women.

Authors:  J O Drife
Journal:  BMJ       Date:  1989-05-13

Review 8.  Biological features of premalignant disease in the human breast.

Authors:  D C Allred; S K Mohsin
Journal:  J Mammary Gland Biol Neoplasia       Date:  2000-10       Impact factor: 2.673

9.  Estrogen receptors, progesterone receptors, and cell proliferation in human breast cancer.

Authors:  M A Fanelli; L M Vargas-Roig; F E Gago; O Tello; R Lucero De Angelis; D R Ciocca
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

10.  Inhibition of Neu-induced mammary carcinogenesis in transgenic mice expressing ERΔ3, a dominant negative estrogen receptor α variant.

Authors:  Vicki L Davis; Firdos Shaikh; Katie M Gallagher; Michael Villegas; Sheri L Rea; J Mark Cline; Claude L Hughes
Journal:  Horm Cancer       Date:  2012-09-12       Impact factor: 3.869

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.